CLINICAL STUDY: MYOCARDIAL INFARCTION
Acute myocardial infarction in the elderly: differences by age
Rajendra H. Mehta, MD*,
Saif S. Rathore, MPH ,
Martha J. Radford, MD, FACC   ,
Yongfei Wang, MS,
Yun Wang, MS and
Harlan M. Krumholz, MD, FACC ||
* Division of Cardiology, University of Michigan, Ann Arbor, Michigan, USA
Section of Cardiovascular Medicine, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
Yale-New Haven Hospital Center for Outcomes Research and Evaluation, New Haven, Connecticut, USA
Qualidigm, Middletown, Connecticut, USA
|| Section of Health Policy and Administration, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut, USA
Manuscript received December 7, 2000;
revised manuscript received May 3, 2001,
accepted May 21, 2001.
Reprint requests and correspondence: Dr. Harlan M. Krumholz, Yale University School of Medicine, 333 Cedar Street, P.O. Box 208025, New Haven, Connecticut 06520-8025
 |
Abstract
|
|---|
OBJECTIVES
We evaluated the clinical characteristics and outcomes of elderly patients hospitalized with acute myocardial infarction (AMI) to describe differences by age.
BACKGROUND
Elderly patients with AMI are perceived as a homogeneous population, though the extent by which clinical characteristics vary among elderly patients has not been well described.
METHODS
Data from 163,140 hospital admissions of Medicare beneficiaries age  65 years between 1994 and 1996 with AMI at U.S. hospitals were evaluated for differences in clinical characteristics and mortality across five age-based strata (in years): 65 to 69, 70 to 74, 75 to 79, 80 to 84 and 85.
RESULTS
Older age was associated with a greater proportion of patients with functional limitations, heart failure, prior coronary disease and renal insufficiency and a lower proportion of male and diabetic patients. Of note, the proportion of patients presenting with chest pain within 6 h of symptom onset, and with ST-segment elevation, was lower in each successive age group. Thirty-day mortality rates were higher in older age groups (65 to 69: 10.9%, 70 to 74: 14.1%, 75 to 79: 18.5%, 80 to 84: 23.2%, 85: 31.2%, p = 0.001 for trend). The effect of age persisted but was attenuated after adjustment for differences in patient characteristics; similar trends were observed for one-year mortality.
CONCLUSIONS
Our data indicate significant age-associated differences in clinical characteristics in elderly patients with AMI, which account for some of the age-associated differences in mortality. The practice of grouping older patients together as a single age group may obscure important age-associated differences.
|
Abbreviations and Acronyms
| | AMI | = acute myocardial infarction | | CABG | = coronary artery bypass graft | | CCP | = Cooperative Cardiovascular Project | | PTCA | = percutaneous transluminal coronary angioplasty |
|
Elderly patients, those 65 years of age and older, represent 13% of the U.S. population yet account for half of hospital admissions for acute myocardial infarction (AMI) and 80% of AMI deaths (1). Despite the greater risk of AMI among older patients and the increasing size of this population (1), the relationship between age, clinical presentation and outcome of AMI in elderly patients is incompletely understood. Many prior observational studies and clinical trials have classified elderly patients as a single population, not specifically evaluating differences in older subgroups, particularly those 75 years of age and older (2–13). The few studies that have explored age-associated differences in AMI presentation and outcomes in this cohort have been limited to small numbers of very elderly patients, usually drawn from individual centers or regions (3,5,7).
Accordingly, we sought to determine how clinical characteristics and outcomes of elderly patients hospitalized with AMI vary by age. Using data from the Cooperative Cardiovascular Project (CCP), a cohort of Medicare beneficiaries hospitalized with AMI, we evaluated variations in clinical characteristics of elderly patients by age, the relationship of age, 30-day and one-year outcomes and the extent to which increased mortality was explained by age-associated variations in clinical characteristics. We anticipated that, rather than representing a homogeneous population, patients 65 years of age and older would exhibit significant differences in clinical characteristics by age and that higher mortality rates would be explained, in part, by differences in patients’ clinical characteristics and treatment.
|
Methods
|
|---|
Study sample.
The CCP sampling strategy has been explained previously (14). We evaluated patients age 65 years and older hospitalized with a confirmed AMI (15). Patients less than 65 years of age (n = 17,593), those without a confirmed AMI (n = 31,186), readmissions for AMI (n = 23,773) and patients transferred from another acute care hospital (n = 36,297) were excluded. In total, 71,629 (30.5%) hospitalizations met one or more of the exclusion criteria; the remaining 163,140 patients constitute the study sample.
Age stratification and patient characteristics.
We categorized patients into five groups based on their age (years): 65 to 69, 70 to 74, 75 to 79, 80 to 84 and 85 and older. Most demographic and clinical characteristics were abstracted as categorical variables in the CCP database. Missing categorical data elements were assumed to be negative for the variable. Missing values for continuous variables were imputed by the median value of the variable, and a separate indicator was used if the percentage of missing values (serum albumin, left ventricular ejection fraction) was more than 5%. Continuous variables were then dichotomized or categorized based on clinical significance. A history of AMI, percutaneous transluminal coronary angioplasty (PTCA), coronary artery bypass grafting (CABG) or congestive heart failure was considered to be evidence of prior coronary artery disease. Renal insufficiency was defined as blood urea nitrogen level >50 mg/dl, or creatinine >2.0 mg/dl on admission (for renal insufficiency as a comorbidity) or highest creatinine >2.0 mg/dl during the hospital stay (for renal insufficiency as a complication). Functional status was considered to be impaired if the patient was unable to ambulate without assistance, was incontinent, or if dementia was present. Heart failure was present on admission if documented by a physician or on the admission chest radiograph interpretation. Patients were also evaluated for use of AMI therapies.
Hospital characteristics, physician characteristics and outcomes.
Hospitals were characterized by linking records with the 1994 American Hospital Association Survey (16). The specialty of the attending physician was determined by linking records to a database of physician-reported specialties obtained from the Health Care Financing Administration (17,18). Patient mortality was determined by linking records with the Medicare Enrollment Database (19).
Statistical methods.
We first examined the association of patient characteristics and older age by chi-square tests and analyses of variance, testing for both global differences and trends by age. Crude patient outcomes were compared across age strata using bivariate analysis, and the independent association of age with 30-day and one-year mortality was evaluated sequentially by multivariable logistic regression analyses adjusted for patient and hospital characteristics, physician specialty, medical therapy use and clustering of patients by hospital. SAS 6.12 software (SAS Institute Inc., Cary, North Carolina) and STATA 6.0 software (Stata Corporation, College Station, Texas) were used for analysis.
|
Results
|
|---|
Patient characteristics.
Older elderly patients hospitalized with AMI were different than younger elderly patients. The proportion of women in the oldest age group was almost double that in the younger group, while nonwhite patients were represented in smaller numbers. Diabetes, smoking, chronic lung disease and a history of prior revascularization were less frequently encountered in older patients. In contrast, a history of heart failure, stroke, renal insufficiency and laboratory evidence of comorbid conditions (low hematocrit, low serum sodium, low albumin) were considerably higher in the older age groups. The proportion of patients with limited functional status was higher in older age groups, affecting almost half of patients age 85 years. Older elderly patients presented less frequently with chest pain, ST-segment elevation, left bundle branch block, within 6 h of symptom onset, and had smaller enzymatic evidence of ischemia (lower creatine kinase) than younger elderly patients. In contrast, heart failure, tachycardia and anterior location of infarct were more common in older individuals (Table 1).
Characteristics of in-hospital care.
Older patients were more likely to be admitted to a facility without revascularization capabilities, less likely to be cared for by a cardiologist, undergo stress testing, left ventricular ejection fraction assessment or invasive cardiovascular procedures during hospitalization compared with younger patients. Crude rates of aspirin, reperfusion therapy (thrombolytic or primary PTCA) and beta-adrenergic blocking agent use were also lower in older elderly patients (Table 2).
Complications and mortality.
Cardiovascular complications, including hypotension, shock, atrial fibrillation, heart failure and stroke and noncardiovascular complications, including pneumonia and renal insufficiency on admission, were more common in older patients. Older patients were more likely to be discharged to a nonacute care facility and less likely to be transferred to another acute-care facility than younger elderly patients (Table 2).
Thirty-day and one-year mortality rates were markedly higher for older elderly patients compared with younger elderly patients, with a trend of successively higher mortality in intermediate age groups (Fig. 1). Age-associated mortality risks were attenuated but persisted after adjustment for patient, hospital and physician characteristics and AMI care. Most of the attenuation was accounted for by patient clinical characteristics and AMI care (Table 3).
View larger version (21K):
[in this window]
[in a new window]
|
Figure 1 Crude 30-day and one-year mortality among different age groups of elderly patients with acute myocardial infarction. Solid bar = 30-day unadjusted; spotted bar = one-year unadjusted; hatched bar = 30-day adjusted; open bar = one-year adjusted.
|
|
|
Discussion
|
|---|
This study provides a comprehensive national perspective on the association of patient characteristics and outcomes by age among a large representative sample of elderly patients with AMI. We observed marked differences by age among patients 65 years of age and older. This finding suggests that the practice of grouping older patients together in a single group of patients 65 years of age and older may provide a perspective that is not representative of all patients in this group. While statistically convenient when studies have small numbers of older patients, the clinical relevance of this approach is questionable.
Previous research has found that older age is associated with a higher prevalence of comorbid conditions, atypical AMI presentation, nondiagnostic electrocardiograms, com-plications and mortality (2–7,10–13,20–22). However, these studies have typically enrolled small numbers of patients, often from clinical trials and, thus, reflect the experience of selected patient populations (2,6,12,13). The clinical detail contained in the CCP allowed us to evaluate characteristics of elderly AMI patients with an unprecedented level of detail in a cohort drawn from a nationally representative population. Though some of our findings are not surprising, CCP provides an opportunity to quantify the association of age and patients’ characteristics in an older group of patients.
Age-associated variation in AMI characteristics.
Comorbidity varied by age, with some comorbid conditions less prevalent in older elderly patients and others more prevalent. A lower prevalence of certain comorbid conditions in older patients, such as diabetes or chronic lung disease, may reflect a survivor effect with earlier mortality among those with disease, leaving fewer patients with disease surviving to older age. The lower prevalence of prior CABG or PTCA in older subjects may indicate a survivor effect, but it may alternatively represent historical practice patterns of fewer coronary interventions when these patients were younger and the current practice of limited procedure use in older patients.
We observed significant variations in the clinical presentation of AMI in elderly patients. Older elderly AMI patients often presented without ST-segment elevation or with electrocardiographic presentations that were difficult to interpret, such as paced rhythms and left bundle branch block. The combination of atypical symptoms, delayed presentation and nondiagnostic electrocardiographic presentation indicates the difficulty in using traditional cues to facilitate early triage and diagnosis. This observation may account for the lower rates of therapy use in older elderly patients. Variations in therapy use are likely further exacerbated by older elderly patients’ treatment at smaller hospitals and management by nonspecialists (17,18,23–25).
Age-associated variation in AMI mortality.
A large portion of age-associated variation in mortality was attributable to age-related variation in patients’ clinical characteristics and AMI care, as adjustment for these factors resulted in the greatest reduction in the age-associated odds of 30-day and one-year mortality. Interestingly, adjustments for specialty of the attending physician and hospital characteristics had only a minor effect on age-associated variations in mortality, suggesting that, while these factors may influence process of care, they have a limited direct contribution to patient outcomes among elderly patients. Nevertheless, even after such adjustments, age remained an important predictor of 30-day and one-year mortality, with a relationship that appeared linear.
The independent association of age with mortality likely reflected the influence of many factors. Older age is associated with significant cardiovascular structural and physiologic changes that might predispose patients to adverse outcomes, including abnormalities of left ventricular diastolic function (26,27), decrease in systemic vascular compliance (28), increase in left ventricular mass index (29) and altered neurohormonal and autonomic influences (30,31). Similarly, coagulation factors (VII, VIII and IX) are increased compared with anticoagulation factors (antithrombin III, Protein C and Protein S) with advancing age, leading to a greater risk of thrombosis in older patients (32). Whether adjustment for these and other important factors (such as the severity of coronary artery disease) associated with age and outcomes not accounted for in this study would lead to further attenuation of the association between age and mortality is unknown.
Study limitations.
The design of the CCP precludes comparisons with representative patients younger than 65 years of age. Our aim, however, was to illuminate differences in characteristics among patients 65 years of age and older since this group is commonly defined as a single group. Additionally, while CCP was a national cohort, it did not include patients enrolled in managed care. The exclusion of managed care patients may have resulted in a healthier cohort due to the increased enrollment of sicker patients in health maintenance organizations (for purposes of obtaining pharmaceutical benefits or other coverage) or a sicker cohort due to the enrollment of healthier patients by risk-averse health maintenance organizations. This issue is unlikely to have substantially affected our main findings.
Conclusions.
Patients 65 years of age and older with AMI are a heterogeneous group by age. Studies that classify elderly patients as a single population may overlook important differences in elderly patients, particularly the oldest, who are often excluded from clinical research studies.
|
Acknowledgments
|
|---|
The analyses upon which this publication is based were performed under Contract Number 500-99-CT01, entitled "Utilization and Quality Control Peer Review Organization for the State of Connecticut," sponsored by the Health Care Financing Administration, Department of Health and Human Services. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government. The author assumes full responsibility for the accuracy and completeness of the ideas presented. This article is a direct result of the Health Care Quality Improvement Program initiated by the Health Care Financing Administration, which has encouraged identification of quality improvement projects derived from analysis of patterns of care, and therefore required no special funding on the part of this contractor. Ideas and contributions to the author concerning experience in engaging with issues presented are welcomed.
|
Footnotes
|
|---|
Dr. Mehta is the recipient of an NIH supported K-30 award through the Center for Clinical Investigation and Therapeutics and the General Clinical Research Center, University of Michigan, Ann Arbor, Michigan.
|
References
|
|---|
1. Gillum BS, Graves EJ, Wood E. National hospital discharge survey: vital and health statistics-series 13: data from the National Health Survey: 133:i–v. 1998:1–51.
2. Marcus FI, Friday K, McCans J, et al. Age-related prognosis after acute myocardial infarction (the Multicenter Diltiazem Postinfarction trial). Am J Cardiol. 1990;65:559–566[CrossRef][Medline]
3. Rich MW, Bosner MS, Chung MK, Shen J, McKenzie JP. Is age an independent predictor of early and late mortality in patients with acute myocardial infarction? Am J Med. 1992;92:7–13[CrossRef][Medline]
4. Goldberg RJ, Gore JM, Gurwitz JH, Alpert JS, Brady P, Strohsnitter W. The impact of age on incidence and prognosis of initial acute myocardial infarction: the Worcester Heart Attack study. Am Heart J. 1989;117:543–549[CrossRef][Medline]
5. Smith SC, Gilpin E, Ahnve S, et al. Outlook for acute myocardial infarction in the very elderly compared with that in patients 65 to 75 years. J Am Coll Cardiol. 1990;16:784–792[Abstract]
6. Maggioni AP, Maseri A, Fresco C, et al. Age-related increase in mortality among patients with first myocardial infarction treated with thrombolysis: the investigators of the Gruppo Italiano per lo Studio della Sopravvivenze nell’Infarto Miocardio (GISSI-2). N Engl J Med. 1993;329:1442–1448[Abstract/Free Full Text]
7. Goldberg RJ, McCormick D, Gurwitz JH, Yarzebski J, Lessard D, Gore JM. Age-related trends in short- and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975 to 1995). Am J Cardiol. 1998;82:1311–1317[CrossRef][Medline]
8. Gurwitz JH, Col NF, Avorn J. The exclusion of elderly and women from clinical trials in acute myocardial infarction. JAMA. 1992;268:1417–1422[Abstract/Free Full Text]
9. European Secondary Prevention Study Group. Translation of clinical trials into practice: a European population-based study of the use of thrombolysis for acute myocardial infarction. Lancet. 1996;347:1203–1207[Medline]
10. Fibrinolytic Therapy Trialists’ Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1,000 patients. Lancet. 1994;343:311–322[CrossRef][Medline]
11. Tofler GH, Muller JE, Stone PH, et al. Factors leading to shorter survival after acute myocardial infarction in patients ages 65 to 75 years compared with younger patients (the MILIS study group). Am J Cardiol. 1988;62:860–867[CrossRef][Medline]
12. White HD, Barbash GI, Califf RM, et al. Age and outcome with contemporary thrombolytic therapy: results from the GUSTO-1 trial. Circulation. 1996;94:1826–1833[Abstract/Free Full Text]
13. Rask-Madsen C, Jensen G, Kober L, Melchior T, Torp-Pedersen C, Hildebrand P. Age-related mortality, clinical heart failure, and ventricular fibrillation in 4,259 Danish patients after acute myocardial infarction. Eur Heart J. 1997;18:1426–1431[Abstract/Free Full Text]
14. Jencks SF, Wilensky GR. The health care quality improvement initiative: a new approach to quality assurance in Medicare. JAMA. 1992;268:900–903[Abstract/Free Full Text]
15. Marciniak TA, Ellerbeck EF, Radford MJ, et al. Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. JAMA. 1998;279:1351–1357[Abstract/Free Full Text]
16. American Hospital Association. The Annual Survey of Hospitals Database. Chicago, IL: 1994.
17. Chen J, Radford MJ, Wang Y, Marciniak TA, Krumholz HM. Do "America’s Best Hospitals" perform better for acute myocardial infarction? N Engl J Med. 1999;340:286–292[Abstract/Free Full Text]
18. Jollis JG, DeLong ER, Peterson ED, et al. Outcome of acute myocardial infarction according to the specialty of the admitting physician. N Engl J Med. 1996;335:1880–1887[Abstract/Free Full Text]
19. Fleming C, Fisher ES, Chang CH, Bubolz TA, Malenka DJ. Study outcomes and hospital utilization in the elderly: the advantages of a merged data base for Medicare and Veterans Affairs hospitals. Med Care. 1992;30:377–391[CrossRef][Medline]
20. Lee KL, Woodlief LH, Topol EJ, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41,021 patients. Circulation. 1995;91:1659–1668[Abstract/Free Full Text]
21. Krumholz HM, Chen J, Wang Y, Radford MJ, Chen YT, Marciniak TA. Comparing AMI mortality among hospitals in patients 65 years of age and older: evaluating methods of risk adjustment. Circulation. 1999;99:2986–2992[Abstract/Free Full Text]
22. Normand SLT, Glickman ME, Sharma GVRK, McNeil BJ. Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients: results from the Cooperative Cardiovascular Project. JAMA. 1996;275:1322–1328[Abstract/Free Full Text]
23. Ayanian JZ, Hauptman PJ, Guadagnoli E, Antman EM, Pashos CL, McNeil BJ. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med. 1994;331:1136–1142[Abstract/Free Full Text]
24. Schreiber TL, Elkhatib A, Grines CL, O’Neill WW. Cardiologist versus internist management of patients with unstable angina: treatment patterns and outcomes. J Am Coll Cardiol. 1995;26:577–582[Abstract]
25. Casale PN, Jones JL, Wolf FE, Pei Y, Eby LM. Patients treated by cardiologists have a lower in-hospital mortality for acute myocardial infarction. J Am Coll Cardiol. 1998;32:885–889[Abstract/Free Full Text]
26. Spirito P, Maron BJ. Influence of aging on Doppler indices of left ventricular diastolic function. Br Heart J. 1988;59:672–679[Abstract/Free Full Text]
27. Downes TR, Nomeir AM, Smith KM, Stewart KP, Little WC. Mechanisms of altered pattern of left ventricular filling with aging in subjects without cardiac disease. Am J Cardiol. 1989;64:523–527[CrossRef][Medline]
28. Avolio AP, Fa-Quan D, Wei-Qiaing L, et al. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation. 1985;71:202–210[Abstract/Free Full Text]
29. Gerstenblith G, Fredericksen J, Yin FCP, Fortuin NF, Lakatta EG, Weisfeldt ML. Echocardiographic assessment of a normal adult aging population. Circulation. 1977;56:273–278[Abstract/Free Full Text]
30. Hogikyan RV, Supiano MA. Arterial alpha-adrenergic responsiveness is decreased and SNS activity is increased in older humans. Am J Physiol. 1994;266:E717–E724
31. Iwase S, Mano T, Watanabe T, Saito M, Kobayashi F. Age-related changes of sympathetic outflow to muscles in humans. J Gerontol. 1991;46:M1–M5[Abstract]
32. Lowe GD, Rumley A, Woodward M, et al. Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA survey. I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol. 1997;97:775–784[CrossRef][Medline]
This article has been cited by other articles:
|
|
|
|
 
M. Komajda, O. Hanon, M. Hochadel, J. L. Lopez-Sendon, F. Follath, P. Ponikowski, V.-P. Harjola, H. Drexler, K. Dickstein, L. Tavazzi, et al.
Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II
Eur. Heart J.,
February 2, 2009;
30(4):
478 - 486.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. V. Ennezat, N. Lamblin, F. Mouquet, O. Tricot, P. Quandalle, V. Aumegeat, O. Equine, O. Nugue, B. Segrestin, P. de Groote, et al.
The effect of ageing on cardiac remodelling and hospitalization for heart failure after an inaugural anterior myocardial infarction
Eur. Heart J.,
August 2, 2008;
29(16):
1992 - 1999.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Jahangir, S. Sagar, and A. Terzic
Aging and cardioprotection
J Appl Physiol,
December 1, 2007;
103(6):
2120 - 2128.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. P. Alexander, L. K. Newby, P. W. Armstrong, C. P. Cannon, W. B. Gibler, M. W. Rich, F. Van de Werf, H. D. White, W. D. Weaver, M. D. Naylor, et al.
Acute Coronary Care in the Elderly, Part II: ST-Segment-Elevation Myocardial Infarction: A Scientific Statement for Healthcare Professionals From the American Heart Association Council on Clinical Cardiology: In Collaboration With the Society of Geriatric Cardiology
Circulation,
May 15, 2007;
115(19):
2570 - 2589.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Ndrepepa, A. Kastrati, J. Mehilli, F.-J. Neumann, J. ten Berg, O. Bruskina, F. Dotzer, M. Seyfarth, J. Pache, J. Dirschinger, et al.
Age-Dependent Effect of Abciximab in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Interventions
Circulation,
November 7, 2006;
114(19):
2040 - 2046.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Pearte, C. D. Furberg, E. S. O'Meara, B. M. Psaty, L. Kuller, N. R. Powe, and T. Manolio
Characteristics and Baseline Clinical Predictors of Future Fatal Versus Nonfatal Coronary Heart Disease Events in Older Adults: The Cardiovascular Health Study
Circulation,
May 9, 2006;
113(18):
2177 - 2185.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. P. Curtis, E. L. Portnay, Y. Wang, R. L. McNamara, J. Herrin, E. H. Bradley, D. J. Magid, M. E. Blaney, J. G. Canto, and H. M. Krumholz
The Pre-Hospital Electrocardiogram and Time to Reperfusion in Patients With Acute Myocardial Infarction, 2000-2002: Findings From the National Registry of Myocardial Infarction-4
J. Am. Coll. Cardiol.,
April 18, 2006;
47(8):
1544 - 1552.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. H. Mehta, C. B. Granger, K. P. Alexander, E. Bossone, H. D. White, and M. H. Sketch Jr
Reperfusion strategies for acute myocardial infarction in the elderly: Benefits and risks
J. Am. Coll. Cardiol.,
February 15, 2005;
45(4):
471 - 478.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Perschbacher, G. S. Reeder, S. J. Jacobsen, S. A. Weston, J. M. Killian, A. Slobodova, and V. L. Roger
Evidence-Based Therapies for Myocardial Infarction: Secular Trends and Determinants of Practice in the Community
Mayo Clin. Proc.,
August 1, 2004;
79(8):
983 - 991.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. H. Mehta, E. Bossone, A. Evangelista, P. T. O'Gara, D. E. Smith, J. V. Cooper, J. K. Oh, J. L. Januzzi, S. Hutchison, D. Gilon, et al.
Acute type B aortic dissection in elderly patients: clinical features, outcomes, and simple risk stratification rule
Ann. Thorac. Surg.,
May 1, 2004;
77(5):
1622 - 1628.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Cohen, G. F. Gensini, F. Maritz, E. P. Gurfinkel, K. Huber, A. Timerman, M. Krzeminska-Pakula, J. Santopinto, C. Hecquet, L. Vittori, et al.
Prospective Evaluation of Clinical Outcomes After Acute ST-Elevation Myocardial Infarction in Patients Who Are Ineligible for Reperfusion Therapy: Preliminary Results From the TETAMI Registry and Randomized Trial
Circulation,
October 21, 2003;
108(90161):
III-14 - 21.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Cohen, G. F. Gensini, F. Maritz, E. P. Gurfinkel, K. Huber, A. Timerman, M. Krzeminska-Pakula, N. Danchin, H. D. White, J. Santopinto, et al.
The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): A randomized trial
J. Am. Coll. Cardiol.,
October 15, 2003;
42(8):
1348 - 1356.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. H. Mehta, K. A. Eagle, L. P. Coombs, E. D. Peterson, F. H. Edwards, F. D. Pagani, G. M. Deeb, S. F. Bolling, and R. L. Prager
Influence of age on outcomes in patients undergoing mitral valve replacement
Ann. Thorac. Surg.,
November 1, 2002;
74(5):
1459 - 1467.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
Top
Abstract
Methods